11.09.2017 10:20:40

Original-Research: euromicron AG (von GBC AG): Buy

^

Original-Research: euromicron AG - von GBC AG

Einstufung von GBC AG zu euromicron AG

Unternehmen: euromicron AG

ISIN: DE000A1K0300

Anlass der Studie: Research Update

Empfehlung: Buy

Kursziel: 10.50 EUR

Letzte Ratingänderung: -

Analyst: Marcel Goldmann, Cosmin Filker

Improvement in sales and profit - Positive effects of the reorganisation

are becoming increasingly visible - Considerable organic growth expected in

2017 - Target price of 10.50 EUR and rating BUY maintained

In H1 2017, euromicron AG generated sales of EUR 153.64 million, thus

around 10.0% more than in the previous year. All business fields

contributed to this increase. The highest absolute sales growth was

generated in the 'Smart Buildings' segment. This segment was able to

increase its sales by EUR 8.12 million to EUR 88.62 million (+10.2%) year-

on-year. The main cause of this was the improved sales performance of

euromicron Deutschland GmbH and ELABO GmbH.

The positive sales performance was also reflected in the earnings figures.

Consequently, EBITDA was reported at -0.88 million EUR, compared to -3.46

million EUR in the previous year. The 'Smart Buildings' segment was mainly

responsible for this significant profit improvement. Moreover, the

operating profit was reduced by restructuring costs of EUR 1.53 million

(PY: EUR 1.77 million). Adjusted for special effects from restructuring

measures, operating EBITDA was EUR 0.65 million, compared to -1.69

million EUR in the previous year.

Of special note here is that the measures announced by management to

increase profitability have been implemented and are increasingly affecting

earnings. The new orientation of the Group, which was initiated in 2015,

was completed for the most part in 2016. Therefore, we are expecting

significantly lower pressure on earnings from reorganisation measures for

FY 2017.

For FY 2017, we expect an improvement in sales and earnings. We expect

sales of EUR 335.00 million, mainly from the 'Critical Infrastructures'

segment, and EBITDA of EUR 12.61 million. These again contain extraordinary

expenses of EUR 2.5 million in connection with the restructuring of the

Group. Adjusted operating EBITDA (adjusted for restructuring effects) is

thus expected to be at EUR 15.1 million; this corresponds to an operating

EBITDA margin of 4.5%. For the following year 2018, we do not expect any

further extraordinary expenses, which should result in EBITDA increasing to

EUR 19.6 million. We expect an EBITDA margin of 5.5% to be achieved as a

result of this.

Based on the confirmed forecasts for FY 2017 and 2018, we have kept our

target price for euromicron AG at the same level. The fair market value

based on our DCF model is EUR 10.50 (previously: EUR 10.50). Based on the

current share price, this results in an unchanged BUY rating. On the basis

of the previous reorganisation successes, the existing potential for

increasing efficiency and potential synergies, as well as the further

expansion of business in the direction of the 'IoT' growth market,

significantly higher margins than have been attained thus far should be

achievable over the long term. Moreover, the company has already shown in

the past that it is capable of doing so. In view of this, it seems to us

that the euromicron AG share is favourably valued.

Die vollständige Analyse können Sie hier downloaden:

http://www.more-ir.de/d/15645.pdf

Kontakt für Rückfragen

Jörg Grunwald

Vorstand

GBC AG

Halderstraße 27

86150 Augsburg

0821 / 241133 0

research@gbc-ag.de

++++++++++++++++

Offenlegung möglicher Interessenskonflikte nach §34b Abs. 1 WpHG und FinAnV Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,5b,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:

http://www.gbc-ag.de/de/Offenlegung.htm

+++++++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------

Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.

Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung

oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

°

Nachrichten zu euromicron AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu euromicron AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

euromicron AG 0,01 -45,45% euromicron AG